Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1085 | 1055 | 1088 | 1180 | 1751 | 3219 |
Fund Return | 8.54% | 5.49% | 8.8% | 5.67% | 11.86% | 12.4% |
Place in category | 48 | 80 | 67 | 173 | 22 | 60 |
% in Category | 6 | 9 | 7 | 33 | 7 | 16 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Schroder Global Equity Fund I Acc | 1.65B | 7.06 | 11.71 | 13.08 | ||
Schroder Global Equity Fund I Inc | 1.65B | 7.04 | 11.70 | 13.07 | ||
Schroder Asian Income Z Acc | 1.32B | 3.93 | 2.15 | 8.61 | ||
Schroder Asian Income Z Inc | 1.32B | 3.93 | 2.16 | 8.62 | ||
Alpha Plus Fund L GBP Accumulation | 1.31B | -0.52 | -5.45 | 9.07 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.99B | 7.74 | 9.50 | 13.38 | ||
Wellington Global Health Care EquiG | 2.53B | 5.25 | 5.27 | 13.12 | ||
Global Health Care Fund W Acc GBP | 117.22M | -8.92 | 12.63 | 14.43 | ||
Adamant Medtech I GBP | 1.53B | 5.06 | 2.30 | 14.28 | ||
Pharmaceuticals Index Trust F Acc | 260.72K | 5.19 | 7.71 | 11.56 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.44 | 807.43 | -0.13% | |
Merck&Co | US58933Y1055 | 7.05 | 129.49 | -1.22% | |
Thermo Fisher Scientific | US8835561023 | 5.08 | 584.05 | -0.17% | |
Elevance Health | US0367521038 | 3.91 | 521.22 | -4.18% | |
Novo Nordisk B | DK0062498333 | 3.56 | 928.8 | -0.92% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review